ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
16/08/2024 08:04:18 | Chg. -0.120 | Volume | Bid22:00:01 | Ask22:00:01 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
99.680EUR | -0.12% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 20.43 bill.EUR | - | - |
Assets
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1,224.7000 | 1,288.8000 | 2,062.6000 | 2,037.9000 | 2,038.6000 | ||||||
Intangible Assets | 707.7000 | 603.5000 | 8,746.3000 | 8,785.4000 | 8,353.4000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | 5,345.7000 | 21,356.6000 | 22,020.8000 | 21,449.2000 | ||||||
Inventories | 1,074.5000 | 1,169 | 2,254.1000 | 1,959.4000 | 2,081.8000 | ||||||
Accounts Receivable | 936.6000 | 912.1000 | 1,446.5000 | 1,604.4000 | 1,494.6000 | ||||||
Cash and Cash Equivalents | 1,080.6000 | 1,083.3000 | 1,459.3000 | 634.1000 | 524.4000 | ||||||
Current Assets | 4,197.7000 | 4,289 | 5,862.9000 | 4,663.6000 | 4,515.3000 | ||||||
Total Assets | 9,580.6000 | 9,634.7000 | 27,219.5000 | 26,684.4000 | 25,964.5000 |
Liabilities
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 146.3000 | 167.1000 | 284.8000 | 364.5000 | 330.2000 | ||||||
Long-term debt | - | 1,425.5000 | 11,556.3000 | 10,665.8000 | 8,917.5000 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | 3,150.2000 | 3,030.9000 | 1,101.5000 | ||||||
Liabilities | 3,280.5000 | 3,112.1000 | 17,330.1000 | 17,014.5000 | 14,229 | ||||||
Share Capital | 2.6000 | 2.7000 | 3 | 3.1000 | 3.1000 | ||||||
Total Equity | 6,297.3000 | 6,522.6000 | 9,889.4000 | 9,669.9000 | 11,735.5000 | ||||||
Minority Interests | 2.8000 | 1.8000 | 1.5000 | 1 | -.3000 | ||||||
Total liabilities equity | 9,580.6000 | 9,634.7000 | 27,219.5000 | 26,684.4000 | 25,964.5000 |
Income Statement
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 4,623.4000 | 4,673.3000 | 5,997.8000 | 7,683.9000 | 7,824.1000 | ||||||
Depreciation (total) | - | 375.8000 | 337.4000 | 565.9000 | 603.9000 | ||||||
Operating Result | 1,035.6000 | 1,034.7000 | 467.3000 | 825.9000 | 808.2000 | ||||||
Interest Income | -54.5000 | 11.9000 | 9.4000 | 2.9000 | 2.2000 | ||||||
Income Before Taxes | 981.1000 | 943.9000 | 153.2000 | 399.6000 | 464.6000 | ||||||
Income Taxes | 221.9000 | 224.9000 | 7 | 95 | -1,348.8000 | ||||||
Minority Interests Profit | 1.8000 | -1.1000 | -.8000 | -1.3000 | -.4000 | ||||||
Net Income | 761 | 720.1000 | 147 | 305.9000 | 1,813.8000 |
Per Share
Cash Flow
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 963.1000 | 1,052.8000 | 816.7000 | 1,632.2000 | 1,582.3000 | ||||||
Cash Flow from Investing Activities | -282.5000 | -469.4000 | -7,557.9000 | -1,691.5000 | -510.8000 | ||||||
Cash Flow from Financing | -467.3000 | -562.4000 | 7,139.8000 | -743.2000 | -1,210.5000 | ||||||
Decrease / Increase in Cash | 196.3000 | 2.7000 | 376 | -825.2000 | -109.7000 | ||||||
Employees | 9,500 | 10,000 | 17,500 | 18,500 | 18,200 |